{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:17:33Z","timestamp":1787167053070,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Gastrointestinal stromal tumors represent the most frequently encountered primary mesenchymal tumors. Whereas the liver and the peritoneum are known to be the preferential metastasis sites, no therapeutic standard has yet been established for the management of bone metastases because of their very low incidence. We report a unique example of a single humerus metastasis of a jejunal gastrointestinal stromal tumor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report the case of a 72-year-old European woman whose jejunal gastrointestinal stromal tumor was resected in 2013 and treated during the following 3\u00a0years with imatinib (400\u00a0mg daily). In 2018, she developed a single humeral bone lesion that was identified as a gastrointestinal stromal tumor metastasis. After 7\u00a0months of imatinib intake, reconstructive surgery was performed. Pathologists confirmed the satisfactory histological regression and assessed the complete tumor resection. The patient is still on imatinib maintenance therapy, with no recurrence reported so far. She fully recovered the upper limb function after following an appropriate rehabilitation program.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Current literature and published case reports indicate that bones are one of the rarest locations of gastrointestinal stromal tumor metastasis (about 1%), with occurrence mainly in the spine. Patients initially diagnosed with gastrointestinal stromal tumor of the small intestine and stomach are more likely to suffer from bone metastasis, compared with other gastrointestinal stromal tumor locations. The median overall survival rate is higher for patients with isolated bone metastasis compared with those having liver metastasis. Metastasis occurs on average 4\u00a0years after the primary, but it may take up to 20\u00a0years, emphasizing the need for long-term clinical and radiological monitoring. Although specific guidelines for such cases have not yet been established, we suggest that a multimodal concerted approach involving surgery or radiotherapy associated with tyrosine kinase inhibitor intake should be considered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Bones are one of the rarest locations of gastrointestinal stromal tumor metastasis. A multidisciplinary collaboration was set up to allow conservative surgery of our patient after several months of imatinib treatment. A year and a half later, the patient is still in complete remission. This specific case supports the concept of an intermediate stage between local and oligometastatic disease that should be managed with a curative aim, as much as possible.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13256-021-02962-8","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T20:03:12Z","timestamp":1629230592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Humeral metastasis as the only recurrence of a 5-year resected gastrointestinal stromal tumor: a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"C.","family":"Braunstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sirveaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kalbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Aubry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Delroeux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Meynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Mihai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Chaigneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,18]]},"reference":[{"key":"2962_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canep.2015.10.031","volume":"40","author":"K S\u00f8reide","year":"2016","unstructured":"S\u00f8reide K, Sandvik OM, S\u00f8reide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39\u201346.","journal-title":"Cancer Epidemiol"},{"issue":"9","key":"2962_CR2","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.dld.2019.07.006","volume":"51","author":"B Landi","year":"2019","unstructured":"Landi B, Blay J-Y, Bonvalot S, Brasseur M, Coindre JM, Emile JF, et\u00a0al. Gastrointestinal stromal tumours (GISTs): French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO). Dig Liver Dis. 2019;51(9):1223\u201331.","journal-title":"Dig Liver Dis"},{"issue":"12","key":"2962_CR3","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1007\/s12094-019-02094-y","volume":"21","author":"DY Yang","year":"2019","unstructured":"Yang DY, Wang X, Yuan WJ, Chen ZH. Metastatic pattern and prognosis of gastrointestinal stromal tumor (GIST): a SEER-based analysis. Clin Transl Oncol. 2019;21(12):1654\u201362.","journal-title":"Clin Transl Oncol"},{"issue":"Suppl 2","key":"2962_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.6004\/jnccn.2010.0116","volume":"8","author":"GD Demetri","year":"2010","unstructured":"Demetri GD, von Mehren M, Antonescu CR, DeMatteo RP, Ganjoo KN, Maki RG, et\u00a0al. NCCN task force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Cancer Netw. 2010;8(Suppl 2):S1\u201341.","journal-title":"J Natl Compr Cancer Netw"},{"key":"2962_CR5","unstructured":"Board WC of TE. Digestive system tumours [En ligne]. Disponible: https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/Digestive-System-Tumours-2019. Accessed 14 Jun 2020."},{"issue":"2","key":"2962_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1053\/j.semdp.2006.09.001","volume":"23","author":"M Miettinen","year":"2006","unstructured":"Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23(2):70\u201383.","journal-title":"Semin Diagn Pathol"},{"issue":"6","key":"2962_CR7","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.21037\/jgo.2017.08.08","volume":"8","author":"N Machairas","year":"2017","unstructured":"Machairas N, Prodromidou A, Molmenti E, Kostakis ID, Sotiropoulos GC. Management of liver metastases from gastrointestinal stromal tumors: where do we stand? J Gastrointest Oncol. 2017;8(6):1100\u20138.","journal-title":"J Gastrointest Oncol"},{"key":"2962_CR8","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.2147\/CMAR.S232936","volume":"12","author":"J Yang","year":"2020","unstructured":"Yang J, Yan J, Zeng M, Wan W, Liu T, Xiao J-R. Bone metastases of gastrointestinal stromal tumor: a review of published literature. Cancer Manag Res. 2020;12:1411\u20137.","journal-title":"Cancer Manag Res."},{"issue":"12","key":"2962_CR9","first-page":"2237","volume":"43","author":"M Kitakaze","year":"2016","unstructured":"Kitakaze M, Hirao M, Miyamoto A, Hamakawa T, Yamamoto K, Nishikawa K, et\u00a0al. A case of GIST of the stomach with long-term survival after multidisciplinary treatment, including four surgical resections of liver metastases. Gan To Kagaku Ryoho. 2016;43(12):2237\u20139.","journal-title":"Gan To Kagaku Ryoho"},{"issue":"7","key":"2962_CR10","first-page":"1258","volume":"110","author":"T Fujisawa","year":"2013","unstructured":"Fujisawa T, Matsumoto Y, Nishizawa A, Takata M. A case of liver and bone metastases after complete resection of gastric GIST effectively treated with radiotherapy and imatinib mesylate. Nihon Shokakibyo Gakkai Zasshi Jpn J Gastro-Enterol. 2013;110(7):1258\u201364.","journal-title":"Nihon Shokakibyo Gakkai Zasshi Jpn J Gastro-Enterol."},{"issue":"1","key":"2962_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00428-017-2138-7","volume":"471","author":"K Kosemehmetoglu","year":"2017","unstructured":"Kosemehmetoglu K, Kaygusuz G, Fritchie K, Aydin O, Yapicier O, Coskun O, et\u00a0al. Clinical and pathological characteristics of gastrointestinal stromal tumor (GIST) metastatic to bone. Virchows Arch. 2017;471(1):77\u201390.","journal-title":"Virchows Arch"},{"key":"2962_CR12","unstructured":"[En ligne]. www.MeDitorial.cz. Gastric gastrointestinal stromal tumor with bone metastases\u2014case report and review of the literature. https:\/\/www.prolekare.cz\/en\/journals\/clinical-oncology\/2014-1-9\/gastric-gastrointestinal-stromal-tumor-with-bone-metastases-case-report-and-review-of-the-literature-47690. Accessed 11 Jan 2020."},{"key":"2962_CR13","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2019.32.133.17985","author":"DM Wejih","year":"2019","unstructured":"Wejih DM, Leila GE, Ali CM, Ramzi N, Ibtissem B, Chadli D. Rectal stromal tumor with an exceptional liver and bone metastatic locations. Pan Afr Med J. 2019. https:\/\/doi.org\/10.11604\/pamj.2019.32.133.17985.","journal-title":"Pan Afr Med J"},{"key":"2962_CR14","doi-asserted-by":"publisher","first-page":"e200397","DOI":"10.1001\/jamasurg.2020.0397","volume":"155","author":"A Gronchi","year":"2020","unstructured":"Gronchi A, Bonvalot S, Poveda Velasco A, Kotasek D, Rutkowski P, Hohenberger P, et\u00a0al. Quality of surgery and outcome in localized gastrointestinal stromal tumors treated within an international intergroup randomized clinical trial of adjuvant imatinib. JAMA Surg. 2020;155:e200397\u2013e200397.","journal-title":"JAMA Surg"},{"issue":"10","key":"2962_CR15","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.ejso.2018.07.004","volume":"44","author":"W Song","year":"2018","unstructured":"Song W, Lv C, Miao D, Zhu Z, Wu Q, Wang Y, et\u00a0al. Development and validation of a nomogram for predicting survival in patients with gastrointestinal stromal tumours. Eur J Surg Oncol. 2018;44(10):1657\u201365.","journal-title":"Eur J Surg Oncol"},{"key":"2962_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21037\/tgh.2019.03.07","volume":"4","author":"M Laurent","year":"2019","unstructured":"Laurent M, Brahmi M, Dufresne A, Meeus P, Karanian M, Ray-Coquard I, et\u00a0al. Adjuvant therapy with imatinib in gastrointestinal stromal tumors (GISTs)\u2014review and perspectives. Transl Gastroenterol Hepatol. 2019;4:24.","journal-title":"Transl Gastroenterol Hepatol."},{"issue":"1","key":"2962_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clon.2014.09.010","volume":"27","author":"AT Falk","year":"2015","unstructured":"Falk AT, Moureau-Zabotto L, Ouali M, Penel N, Italiano A, Bay J-O, et\u00a0al. Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French Sarcoma Group. Clin Oncol. 2015;27(1):48\u201355.","journal-title":"Clin Oncol"},{"key":"2962_CR18","unstructured":". Awc K. Hepatic metastasis from colorectal cancer. J Gastrointest Oncol. 2019; https:\/\/pubmed.ncbi.nlm.nih.gov\/31949948\/. Accessed 29 Sept 2020."},{"key":"2962_CR19","unstructured":"F X, B T, Tq J, Cl D. Current status of surgical treatment of colorectal liver metastases. World J Clin Cases. 2018. https:\/\/pubmed.ncbi.nlm.nih.gov\/30510936\/. Accessed 29 Sept 2020."},{"issue":"7","key":"2962_CR20","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S1470-2045(20)30168-6","volume":"21","author":"J-Y Blay","year":"2020","unstructured":"Blay J-Y, Serrano C, Heinrich MC, Zalcberg J, Bauer S, Gelderblom H, et\u00a0al. Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Oncol. 2020;21(7):923\u201334.","journal-title":"Lancet Oncol"},{"issue":"4","key":"2962_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s40265-020-01275-2","volume":"80","author":"S Dhillon","year":"2020","unstructured":"Dhillon S. Avapritinib: first approval. Drugs. 2020;80(4):433\u20139.","journal-title":"Drugs"},{"issue":"29","key":"2962_CR22","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.1200\/JCO.2006.06.2265","volume":"24","author":"MC Heinrich","year":"2006","unstructured":"Heinrich MC, Corless CL, Blanke CD, Demetri GD, Joensuu H, Roberts PJ, et\u00a0al. Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. J Clin Oncol. 2006;24(29):4764\u201374.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2962_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/path.2382","volume":"216","author":"B Liegl","year":"2008","unstructured":"Liegl B, Kepten I, Le C, Zhu M, Demetri GD, Heinrich MC, et\u00a0al. Heterogeneity of kinase inhibitor resistance mechanisms in GIST. J Pathol. 2008;216(1):64\u201374.","journal-title":"J Pathol"},{"issue":"4","key":"2962_CR24","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1349-7006.2008.00727.x","volume":"99","author":"T Nishida","year":"2008","unstructured":"Nishida T, Kanda T, Nishitani A, Takahashi T, Nakajima K, Ishikawa T, et\u00a0al. Secondary mutations in the kinase domain of the KIT gene are predominant in imatinib-resistant gastrointestinal stromal tumor. Cancer Sci. 2008;99(4):799\u2013804.","journal-title":"Cancer Sci"},{"issue":"6","key":"2962_CR25","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1158\/1078-0432.CCR-05-1211","volume":"12","author":"E Wardelmann","year":"2006","unstructured":"Wardelmann E, Merkelbach-Bruse S, Pauls K, Thomas N, Schildhaus H-U, Heinicke T, et\u00a0al. Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate. Clin Cancer Res. 2006;12(6):1743\u20139.","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02962-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-02962-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02962-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T20:03:26Z","timestamp":1629230606000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-02962-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,18]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2962"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-02962-8","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,18]]},"assertion":[{"value":"8 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"428"}}